Malignant mesothelioma: new insights into tumour biology and immunology as a basis for new treatment approaches.

This publication has 63 references indexed in Scilit:

• Generation of an antitumour immune response to a murine mesothelioma cell line by the transfection of allogeneic mhc genes
  International Journal of Cancer, 1994
• The B7 and CD28 receptor families
  Immunology Today, 1994
• in vitro effects of recombinant human interferon gamma on human mesothelioma cell lines
  International Journal of Cancer, 1993
• An analysis of the relationship between γδ T cell receptor V gene usage and non‐major histocompatibility complex‐restricted cytotoxicity
  Immunology & Cell Biology, 1993
• Tumor Rejection After Direct Costimulation of CD8 ⁺ T Cells by B7-Transfected Melanoma Cells
  Science, 1993
• Immunoreactivity for the β chain of the platelet‐derived growth factor receptor in malignant mesothelioma and non‐neoplastic mesothelium
  The Journal of Pathology, 1992
• An autocrine mitogenic activity produced by a pleural human mesothelioma cell line
  International Journal of Cancer, 1992
• Activity of doxorubicin and cisplatin combination chemotherapy in patients with diffuse malignant pleural mesothelioma. An italian lung cancer task force (FONICAP) phase II study
  Cancer, 1991
• Cisplatin administered by the intracavitary route as treatment for malignant mesothelioma
  Cancer, 1986
• Malignant mesothelioma. The eastern cooperative oncology group (ECOG) experience
  Cancer, 1983